Records containing: Inclusion Body Myositis (IBM)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-02Étude de l'Effet de la Rapamycine Sur la Force Musculaire et la réponse Immunitaire au Cours de la Myosite à Inclusions: étude RAPAMI"
-
CLINICAL_TRIALS study record update · 2025-07-28An Open-label, Multicenter Study to Evaluate the Long-term Safety and Efficacy of Ulviprubart (ABC008) in Subjects Who Have Completed a Trial of Ulviprubart for the Treatment of Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2025-06-24Exercise as Treatment for Patients With Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2017-02-09Pilot Study of Natalizumab in the Treatment of Patients With Inclusion Body Myositis